95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.59%
Negative revenue growth while FSM stands at 34.88%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.62%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.52%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.52%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.05%
Share reduction more than 1.5x FSM's 56.05%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.11%
Diluted share reduction more than 1.5x FSM's 47.44%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-44.76%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-6.99%
Negative OCF growth while FSM is at 33.26%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
31.55%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
13.95%
10Y revenue/share CAGR under 50% of FSM's 39.71%. Michael Burry would suspect a lasting competitive disadvantage.
12.85%
5Y revenue/share CAGR at 50-75% of FSM's 21.63%. Martin Whitman would worry about a lagging mid-term growth trajectory.
42.63%
3Y revenue/share CAGR at 75-90% of FSM's 50.85%. Bill Ackman would expect new product strategies to close the gap.
-5.57%
Negative 10Y OCF/share CAGR while FSM stands at 101.45%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
21.90%
Positive OCF/share growth while FSM is negative. John Neff might see a comparative advantage in operational cash viability.
82.91%
Positive 3Y OCF/share CAGR while FSM is negative. John Neff might see a big short-term edge in operational efficiency.
-21.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
59.10%
Positive 5Y CAGR while FSM is negative. John Neff might view this as a strong mid-term relative advantage.
290.73%
Positive short-term CAGR while FSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
86.13%
10Y equity/share CAGR at 50-75% of FSM's 156.00%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
18.37%
Below 50% of FSM's 63.46%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
14.03%
3Y equity/share CAGR at 50-75% of FSM's 25.40%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
323.53%
Dividend/share CAGR of 323.53% while FSM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
190.02%
Dividend/share CAGR of 190.02% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.46%
3Y dividend/share CAGR of 66.46% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-24.73%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
280.32%
Inventory growth well above FSM's 35.55%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.09%
Asset growth well under 50% of FSM's 84.84%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.97%
Under 50% of FSM's 17.59%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-7.67%
We’re deleveraging while FSM stands at 24.41%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-36.65%
We cut SG&A while FSM invests at 22.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.